Merck misses profit estimates, forecasts larger hit to 2021 sales from Covid-19 pandemic | Malay Mail

  • 📰 malaymail
  • ⏱ Reading Time:
  • 28 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 15%
  • Publisher: 86%

Malaysia Headlines News

Malaysia Latest News,Malaysia Headlines

BERLIN, April 29 — Merck & Co Inc today missed estimates for first-quarter profit and forecast a bigger hit to 2021 sales than its previous estimate as the pandemic hurt demand for its drugs that need to be administered in a clinic. Shares fell nearly 3 per cent to US$74.95 (RM307) before the...

Thursday, 29 Apr 2021 07:38 PM MYT

Shares fell nearly 3 per cent to US$74.95 before the opening bell as the company also disclosed a roughly US$600 million hit to first-quarter sales from the health crisis. A large blow was seen on sales of non-Covid-19 vaccines, including Gardasil, a vaccine to prevent cancers caused by the human papillomavirus virus, in the United States and Europe. Gardasil sales tumbled 16.4 per cent to US$917 million.

Sales of blockbuster cancer drug Keytruda rose 18.7 per cent to US$3.90 billion, but missed Wall Street estimates of US$3.98 billion.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 1. in MY

Malaysia Latest News, Malaysia Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.